NO984858D0 - Nye steroider, deres anvendelse som medikamenter, fremgangsmÕte for deres fremstilling, mellomproduktene ved fremgangsmÕten samt preparater inneholdende steroidene - Google Patents

Nye steroider, deres anvendelse som medikamenter, fremgangsmÕte for deres fremstilling, mellomproduktene ved fremgangsmÕten samt preparater inneholdende steroidene

Info

Publication number
NO984858D0
NO984858D0 NO984858A NO984858A NO984858D0 NO 984858 D0 NO984858 D0 NO 984858D0 NO 984858 A NO984858 A NO 984858A NO 984858 A NO984858 A NO 984858A NO 984858 D0 NO984858 D0 NO 984858D0
Authority
NO
Norway
Prior art keywords
steroids
intermediates
drugs
preparation
preparations containing
Prior art date
Application number
NO984858A
Other languages
English (en)
Other versions
NO312035B1 (no
NO984858L (no
Inventor
Neerja Bhatnagar
Andru Claussner
Christian Marchandeau
Mich Le Resche Rigon
Jean-Georges Teutsch
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO984858D0 publication Critical patent/NO984858D0/no
Publication of NO984858L publication Critical patent/NO984858L/no
Publication of NO312035B1 publication Critical patent/NO312035B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19984858A 1996-04-18 1998-10-16 Nye steroider, fremgangsmåte for deres fremstilling, mellomproduktene ved fremgangsmåten samt preparater inneholdendesteroidene NO312035B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604845A FR2747680B1 (fr) 1996-04-18 1996-04-18 Nouveaux steroides, leur application a titre de medicaments, leur procede de preparation, les intermediaires de ce procede et les compositions pharmaceutiques les renfermant
PCT/FR1997/000693 WO1997039018A1 (fr) 1996-04-18 1997-04-17 Nouveaux derives de pregnane sans substituent en position 17-alpha-, leur application a titre de medicament, leur procede de preparation, les intermediaires de ce procede et les compositions les contenant

Publications (3)

Publication Number Publication Date
NO984858D0 true NO984858D0 (no) 1998-10-16
NO984858L NO984858L (no) 1998-10-16
NO312035B1 NO312035B1 (no) 2002-03-04

Family

ID=9491327

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984858A NO312035B1 (no) 1996-04-18 1998-10-16 Nye steroider, fremgangsmåte for deres fremstilling, mellomproduktene ved fremgangsmåten samt preparater inneholdendesteroidene

Country Status (24)

Country Link
US (2) US6274572B1 (no)
EP (1) EP0898579B1 (no)
JP (1) JP2000508333A (no)
KR (1) KR100450854B1 (no)
CN (1) CN1144813C (no)
AR (1) AR006706A1 (no)
AT (1) ATE189896T1 (no)
AU (1) AU721347B2 (no)
BR (1) BR9708696A (no)
CA (1) CA2251642A1 (no)
CZ (1) CZ293156B6 (no)
DE (1) DE69701328T2 (no)
ES (1) ES2143306T3 (no)
FR (1) FR2747680B1 (no)
GR (1) GR3033249T3 (no)
IL (1) IL126539A (no)
NO (1) NO312035B1 (no)
PL (1) PL186414B1 (no)
PT (1) PT898579E (no)
RU (1) RU2177951C2 (no)
TR (1) TR199802091T2 (no)
TW (1) TW386085B (no)
WO (1) WO1997039018A1 (no)
ZA (1) ZA973289B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0984782A2 (en) * 1997-06-04 2000-03-15 Akzo Nobel N.V. Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
ATE334682T1 (de) * 2000-03-31 2006-08-15 Us Gov Health & Human Serv Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
PT2805720T (pt) 2008-05-28 2019-09-23 Reveragen Biopharma Inc Moduladores esteroides não hormonais de nf-kb para tratamento de uma doença
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN107365342B (zh) * 2017-07-17 2019-08-06 苏州博源医疗科技有限公司 醛固酮衍生物、免疫原、及合成方法、特异性抗体和检测试剂及制备方法、试剂盒
CN107973836B (zh) * 2017-10-19 2020-05-12 苏州博源医疗科技有限公司 醛固酮衍生物及其制备方法、醛固酮均相酶免疫检测试剂
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2837544A (en) * 1957-03-25 1958-06-03 Olin Mathieson Synthesis of steroids
DE1169444B (de) * 1961-02-22 1964-05-06 Schering Ag Verfahren zur Herstellung von ?-16ª‡-Methylsteroiden
FR7605M (no) * 1968-04-23 1970-01-19
JPS615093A (ja) * 1984-06-15 1986-01-10 Mitsubishi Chem Ind Ltd 新規な２１位シアノ化コルチコイド誘導体およびその製法
US5223493A (en) * 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
WO1987001706A2 (en) * 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
JPS63303994A (ja) * 1987-06-04 1988-12-12 Taisho Pharmaceut Co Ltd ２１−置換チオステロイド化合物
US4968822A (en) * 1987-12-11 1990-11-06 Taisho Pharmaceutical Co., Ltd. 21-alkoxysteroid compounds
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use

Also Published As

Publication number Publication date
AU2703297A (en) 1997-11-07
AU721347B2 (en) 2000-06-29
ZA973289B (en) 1998-04-17
TW386085B (en) 2000-04-01
IL126539A (en) 2003-07-06
ATE189896T1 (de) 2000-03-15
PL186414B1 (pl) 2004-01-30
CZ332398A3 (cs) 1999-11-17
CA2251642A1 (fr) 1997-10-23
CN1144813C (zh) 2004-04-07
NO312035B1 (no) 2002-03-04
EP0898579B1 (fr) 2000-02-23
DE69701328D1 (de) 2000-03-30
EP0898579A1 (fr) 1999-03-03
FR2747680B1 (fr) 1998-07-03
KR20000005546A (ko) 2000-01-25
US20020002155A1 (en) 2002-01-03
CN1222160A (zh) 1999-07-07
JP2000508333A (ja) 2000-07-04
GR3033249T3 (en) 2000-09-29
DE69701328T2 (de) 2000-08-24
WO1997039018A1 (fr) 1997-10-23
TR199802091T2 (xx) 2000-09-21
BR9708696A (pt) 1999-08-03
US6274572B1 (en) 2001-08-14
IL126539A0 (en) 1999-08-17
RU2177951C2 (ru) 2002-01-10
PL329387A1 (en) 1999-03-29
ES2143306T3 (es) 2000-05-01
NO984858L (no) 1998-10-16
FR2747680A1 (fr) 1997-10-24
PT898579E (pt) 2000-07-31
CZ293156B6 (cs) 2004-02-18
US6492536B2 (en) 2002-12-10
KR100450854B1 (ko) 2004-12-16
AR006706A1 (es) 1999-09-08

Similar Documents

Publication Publication Date Title
DK0680967T3 (da) Nye forbindelser afledt af erythromycin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
NO20002835D0 (no) 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor
DK0663913T3 (da) Nye substituerede pyrazolderivater, fremgangsmåder til deres fremstilling samt deres anvendelse som herbicider
NO954942L (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler
DK0998473T3 (da) Krystalmodifikation af et N-phenyl-2-pyrimidinaminderivat, fremgangsmåder til fremstilling deraf samt dets anvendelse
NO964639L (no) Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
HUP9900947A3 (en) Process for the preparation of piperidine derivatives, intermediates and preparation thereof
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
NO995745L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medikamenter
NO984858L (no) Nye steroider, deres anvendelse som medikamenter, fremgangsmÕte for deres fremstilling, mellomproduktene ved fremgangsmÕten samt preparater inneholdende steroidene
NO960364D0 (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
DK0782575T3 (da) Substituerede pyrazol-pyrazol-derivater, fremgangsmåde til deres fremsstilling samt deres anvendelse som midler med herbicid virkning
NO20003661L (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
DK0931088T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
HUP0002351A3 (en) Methods for the preparation of biphenyl isoxazole sulfonamides, intermediates and process for preparing them
NO992859L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
NO20002483D0 (no) Nye 19-nor-steroider substituert i posisjon 11B, fremgangsmÕte for fremstilling av slike samt mellomprodukter, deres anvendelse som medisiner, og farmasøytiske preparater inneholdende disse
NO972434L (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO993125D0 (no) Steroider substituert i posisjon 11, fremgangsmÕte for fremstilling av disse, deres anvendelse som medisiner samt farmas°ytiske preparater inneholdende disse
NO970697D0 (no) Substituerte tiofenalkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene
DK439789A (da) Ethansulfonamidforbindelser, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende samme samt mellemprodukter til anvendelse ved fremgangsmaaden
NO168032C (no) Fremgangsmaate til fremstilling av alfa-(1-metyletyl)-3,4-dimetoksybenzen-acetonitril, samt mellomprodukt som dannes ved fremgangsmaaten.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees